Research and Markets has announced the addition of the "Bone Morphogenetic Protein Market Analysis By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial Surgery), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2013 - 2024" report to their offering.

The global bone morphogenetic protein (BMP) market size is expected to reach over USD 644.6 million by 2024. Increasing incidence of spinal fusion, trauma, and small bone surgeries coupled with demand for faster bone recovery are the key drivers affirming growth of BMP market.

Low back pain and spinal disc dislocation are some of the most common occupational hazards. Over 75% of such disorders require spinal surgery after noninvasive treatment options are unable to provide any relief. Minimally invasive surgery, shorter hospital stays, and fast recovery are common demands observed among patients. BMP has gained high acceptance among orthopedic surgeons in recent years owing to its ability to cater above mentioned benefits

Sport-related injuries, growing geriatric population, and increasing awareness about osteoinduction products as an alternative to bone grafting are other drivers accentuating market growth. BMP has reported outstanding results over bone graft, such as lack of donor morbidity, extensive surgical procedure, higher recovery time, pain & numbness, and high cost.

Key Topics Covered:

1 Research Methodology & Scope

2 Executive Summary

3 Bone Morphogenetic Protein Market Variables, Trends & Scope

4 Bone Morphogenetic Protein Market Type Estimates & Trend Analysis

5 Bone Morphogenetic Protein Market Application Estimates & Trend Analysis

6 Bone Morphogenetic Protein Market Regional Estimates & Trend Analysis, by Type and Application

7 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/rcjwcb/bone